SpecGx LLC FDA Inspection Record

FEI 1317295 · Inspections, Form 483s, warning letters and import refusals

SpecGx LLC is an FDA-registered facility (FEI 1317295) located in Hobart, NY, US. Registered operations: ANALYSIS; DISTRIBUTE; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 6 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Mar 13, 2020: No Action Indicated (NAI)
Inspections on record
6 (4 VAI, 2 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
3, latest May 25, 2012

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 13, 2020No Action Indicated (NAI)No citations listed
Apr 6, 2018No Action Indicated (NAI)No citations listed
Jan 29, 2016Voluntary Action Indicated (VAI)Storage under appropriate conditions (21 CFR 211.142(b))
Accurate reproduction included (21 CFR 211.188(a))
Aug 30, 2013Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Establishment of time limitations (21 CFR 211.111)
Approval and review of procedures (21 CFR 211.100(a))
Apr 20, 2012Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Establishment of time limitations (21 CFR 211.111)
Sanitation--buildings not clean, free of infestation (21 CFR 211.56(a))
and 2 more
Jan 27, 2010Voluntary Action Indicated (VAI)Clothing appropriate for duties performed (21 CFR 211.28(a))
Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Buildings not maintained in good state of repair (21 CFR 211.58)
Written warehousing procedures established/followed (21 CFR 211.142)

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
May 25, 2012Class IID-1430-2012Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5 mg/500 mg per 15 mL, 16 fl oz… and 1 more product
Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.
Mar 15, 2012Class IIID-1358-2012Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 100 count bottle, Rx only… and 2 more products
Stability Data does not Support Expiration Date: Covidien Mallinckrodt Inc. is conducting a voluntary recall of Methylin Chewable Tablets…
Jan 14, 2004Class IID-105-4Oxycodone Hydrochloride Oral Concentrate Solution, 20 mg/mL, 30 mL bottle, Rx only…
Defective Dropper; the ink graduated markings dissolve when stored in the product which may result in inaccurate administration of…

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

6 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 29, 201610 years or older, so it adds no points0
Inspection classified VAIAug 30, 201310 years or older, so it adds no points0
Class II recall D-1430-2012, this FEI as the recalling firmMay 25, 201210 years or older, so it adds no points0
Inspection classified VAIApr 20, 201210 years or older, so it adds no points0
Inspection classified VAIJan 27, 201010 years or older, so it adds no points0
Class II recall D-105-4, this FEI as the recalling firmJan 14, 200410 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing SpecGx LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check SpecGx LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
SpecGx LLC
Location
Hobart, NY (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; DISTRIBUTE; MANUFACTURE; PACK; RELABEL; REPACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.